← Open Payments lookup

TSOVINAR TEKKELIAN: Open Payments

NPI 1558447607 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,687 in 67 payments from 20 companies in 2025. Trend: 2023 $1,977 · 2024 $1,723 · 2025 $1,687

Food & beverage: $1,687
CompanyPaymentsAmount
ABBVIE INC.9$228
Ardelyx, Inc.8$227
Amgen Inc.8$209
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$122
Aimmune Therapeutics, Inc.4$114
Novo Nordisk Inc5$105
Lundbeck LLC4$101
Novartis Pharmaceuticals Corporation4$93
Boehringer Ingelheim Pharmaceuticals, Inc.3$63
Takeda Pharmaceuticals U.S.A., Inc.3$62

Products named: IBSRELA, REXULTI, CAPLYTA, EVENITY, ZENPEP, Ozempic, LINZESS, LEQVIO.

Industry payments across CA — which companies pay providers there.